C81.0 Category · further specificity required Nodular lymphocyte predominant Hodgkin lymphoma
ICD-10-CM C81.0 identifies “Nodular lymphocyte predominant Hodgkin lymphoma” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
No additional notes.
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C81 · Hodgkin lymphoma
Excludes 11
personal history of Hodgkin lymphoma (Z85.71)
More specific codes
C81.00Nodular lymphocyte predominant Hodgkin lymphoma, unspecified siteBillable / specificC81.01Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neckBillable / specificC81.02Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodesBillable / specificC81.03Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodesBillable / specificC81.04Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limbBillable / specificC81.05Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limbBillable / specificC81.06Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodesBillable / specificC81.07Nodular lymphocyte predominant Hodgkin lymphoma, spleenBillable / specificC81.08Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sitesBillable / specificC81.09Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sitesBillable / specificC81.0ANodular lymphocyte predominant Hodgkin lymphoma, in remissionBillable / specificOfficial index references
Official index references (1)
Lymphoma(of) (malignant) (1)
References from other codes (2)
Excludes 1 · nodular lymphocyte predominant Hodgkin lymphoma (C81.0-)
Code first · lymphoma (C81.0-C85.9, C96.0-C96.9)
History
Code history
No recorded change since first observation
ChangedUnchanged
FY2016
Effective from
- First observed
Nodular lymphocyte predominant Hodgkin lymphoma
Category — select a more specific code
CDC/NCHS · FY2016All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.